Their analyses showed that IDH‐mutant glioma has lower expression of PD‐L1 (CD274) in comparison to IDH‐wildtype, across all grades, with significant adjusted P‐value of < 0.05 for grade IV (both CGGA and TCGA), and grade III (TCGA). This evidence concerns the gene IDH2 and central nervous system cancer.